Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Technology
Share your love
The Art and Science of Presbyopia Correction: Navigating the IOL Patient Journey | Ophthalmology Times
Presbyopia-correcting IOLs have undergone a dramatic transformation in recent years. The once-limited options for patients seeking reduced spectacle dependence after cataract surgery have evolved into a diverse and sophisticated array of IOL technologies, including trifocal, extended depth-of-focus (EDOF), small-aperture, light-adjustable,…
Phase 1 trial confirms safety and tolerability of Huons’ dry eye therapy | Ophthalmology Times
(Image Credit: AdobeStock) Huons Co, a pharmaceutical subsidiary of Huons Group, received phase 1 Clinical Study Results (CSR) for HUC1-394, an eye drop for the treatment of dry eye disease (DED). HUC1-394 is a peptide-based eye drop for dry eyes,…
Q&A: As DMEI turns 50, R. Michael Siatkowski, MD, MBA, looks to the future | Ophthalmology Times
R. Michael Siatkowski, MD, MBA, reflects on 50 years of innovation, research, and patient care at the Dean McGee Eye Institute and shares his vision for the future of ophthalmology. (Courtesy of Dean McGee Eye Institute) As Dean McGee Eye…
AAO 2025 Takeaways: Cornea, refractive surgery, and aesthetics redefined | Ophthalmology Times
(Image Credit: AdobeStock/Pixel-Shot) Editor’s Note: This content was generated with the assistance of AI. AAO 2025 delivered major insights into anterior segment innovation, spanning corneal cross-linking care, refractive surgery evolution, and energy-based aesthetic technology. Presentations from Reena Gupta, MD; Arjan…
Harrow completes acquisiton of Melt Pharmaceuticals | Ophthalmology Times
(Image Credit: AdobeStock/Parradee) Harrow has completed the acquisition of Melt Pharmaceuticals, which includes product candidates MELT-210, MELT-300, and MELT-400 based on the Zydis ODT (oral dissolving tablet) drug delivery platform. Melt will now be fully integrated into Harrow’s operations to…
AAO 2025: The value of RGB imaging in OCT | Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, a professor of ophthalmology at UCLA and the Doheny Eye Institute, discussed advancements in ophthalmological imaging technology, specifically focusing on the Silverstone platform with RGB imaging capabilities. The key innovation of this platform is the…
AAO 2025: Innovations in surgical visualization and imaging | Ophthalmology Times
Katherine Talcott, MD, a retina specialist at the Cleveland Clinic’s Cole Eye Institute, explores the evolving landscape of retinal surgery, focusing on emerging imaging technologies. She begins by distinguishing 2 main categories of technological advancements: intraoperative optical coherence tomography (OCT)…
Sight Sciences reports new data supporting long-term efficacy of OMNI Surgical System | Ophthalmology Times
(Image Credit: AdobeStock/andranik123) Sight Sciences has released results from 3 published manuscripts analyzing prospective study data and retrospective registry data that the company claims “further demonstrate the value of an interventional mindset in treating glaucoma.” One of the studies was…
Q&A: James Chelnis discusses AAO 2025 presentation on aesthetic facial surgery | Ophthalmology Times
Image credit: AdobeStock/Viacheslav Yakobchuk James Chelnis, MD, FACS, is an ophthalmic plastic and reconstructive surgeon at Manhattan Face & Eye. At the 2025 American Academy of Ophthalmology meeting held in Orlando, Florida, he gave a presentation titled, “Introduction to Aesthetic…
LASIK and beyond: Navigating the changing landscape of refractive surgery | Ophthalmology Times
Ophthalmologists share how emerging LASIK techniques and technologies are improving outcomes and shaping the future of refractive surgery. (Image credit: AdobeStock/rohane) Refractive surgery continues to transform, with innovations in LASIK and other vision-correction procedures improving precision and patient outcomes. The…